Generic diagnostic platform
As a response to the COVID-19 pandemic, we developed and launched Attana Virus Analytics™ (AVA™) – our first diagnostic solution. The AVA™ platform consists of our Cell™ 250 instrument, consumables, protocols and training services, offering clinical labs a rapid path to gaining in-depth data from patient serum samples and the ability to create patient immunity profiles over time.
We have already commenced work on broadening our diagnostic portfolio with additional assays and are exploring the potential for a point-of-care device based on whole blood samples.
Attana is currently certified for the development and sales of life science analysis systems and associated consultancy services for research purposes. Attana is listed by the The Swedish Public Health Agency as a supplier of instruments for COVID-19 testing.
Attana Virus Analytics™
The next generation of virus intelligence
Detailed patient classification based on superior methodology and analysis of antibody and virus metrics
Scalable technology allowing for a wide range of commercial applications and large-scale testing
Streamlined technology used in research and drug development since 2005; patent and IP protected viral testing process